vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and XPLR Infrastructure, LP (XIFR). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $249.0M, roughly 2.0× XPLR Infrastructure, LP). XPLR Infrastructure, LP runs the higher net margin — 11.2% vs 6.8%, a 4.4% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -15.3%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -1.6%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

XPLR Infrastructure is a publicly traded subsidiary of NextEra Energy, is a Juno Beach, Florida-based renewable energy company.

MD vs XIFR — Head-to-Head

Bigger by revenue
MD
MD
2.0× larger
MD
$493.8M
$249.0M
XIFR
Growing faster (revenue YoY)
MD
MD
+13.6% gap
MD
-1.7%
-15.3%
XIFR
Higher net margin
XIFR
XIFR
4.4% more per $
XIFR
11.2%
6.8%
MD
Faster 2-yr revenue CAGR
MD
MD
Annualised
MD
-0.1%
-1.6%
XIFR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MD
MD
XIFR
XIFR
Revenue
$493.8M
$249.0M
Net Profit
$33.7M
$28.0M
Gross Margin
Operating Margin
9.9%
-19.3%
Net Margin
6.8%
11.2%
Revenue YoY
-1.7%
-15.3%
Net Profit YoY
10.5%
124.3%
EPS (diluted)
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
XIFR
XIFR
Q4 25
$493.8M
$249.0M
Q3 25
$492.9M
$315.0M
Q2 25
$468.8M
$342.0M
Q1 25
$458.4M
$282.0M
Q4 24
$502.4M
$294.0M
Q3 24
$511.2M
$319.0M
Q2 24
$504.3M
$360.0M
Q1 24
$495.1M
$257.0M
Net Profit
MD
MD
XIFR
XIFR
Q4 25
$33.7M
$28.0M
Q3 25
$71.7M
$-37.0M
Q2 25
$39.3M
$79.0M
Q1 25
$20.7M
$-98.0M
Q4 24
$30.5M
$-115.0M
Q3 24
$19.4M
$-40.0M
Q2 24
$-153.0M
$62.0M
Q1 24
$4.0M
$70.0M
Operating Margin
MD
MD
XIFR
XIFR
Q4 25
9.9%
-19.3%
Q3 25
13.8%
1.6%
Q2 25
12.8%
26.3%
Q1 25
7.0%
-82.6%
Q4 24
7.8%
-188.1%
Q3 24
6.6%
15.4%
Q2 24
-31.3%
18.3%
Q1 24
3.2%
-8.2%
Net Margin
MD
MD
XIFR
XIFR
Q4 25
6.8%
11.2%
Q3 25
14.5%
-11.7%
Q2 25
8.4%
23.1%
Q1 25
4.5%
-34.8%
Q4 24
6.1%
-39.1%
Q3 24
3.8%
-12.5%
Q2 24
-30.3%
17.2%
Q1 24
0.8%
27.2%
EPS (diluted)
MD
MD
XIFR
XIFR
Q4 25
$0.40
Q3 25
$0.84
$-0.40
Q2 25
$0.46
$0.84
Q1 25
$0.24
$-1.05
Q4 24
$0.37
Q3 24
$0.23
$-0.43
Q2 24
$-1.84
$0.66
Q1 24
$0.05
$0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
XIFR
XIFR
Cash + ST InvestmentsLiquidity on hand
$375.2M
$960.0M
Total DebtLower is stronger
$570.5M
$6.2B
Stockholders' EquityBook value
$865.9M
$10.9B
Total Assets
$2.2B
$19.6B
Debt / EquityLower = less leverage
0.66×
0.57×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
XIFR
XIFR
Q4 25
$375.2M
$960.0M
Q3 25
$340.1M
$711.0M
Q2 25
$224.7M
$880.0M
Q1 25
$99.0M
$1.5B
Q4 24
$229.9M
$283.0M
Q3 24
$103.8M
$290.0M
Q2 24
$19.4M
$281.0M
Q1 24
$8.0M
$245.0M
Total Debt
MD
MD
XIFR
XIFR
Q4 25
$570.5M
$6.2B
Q3 25
$577.2M
Q2 25
$583.9M
Q1 25
$590.5M
Q4 24
$597.1M
$5.3B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MD
MD
XIFR
XIFR
Q4 25
$865.9M
$10.9B
Q3 25
$890.7M
$11.0B
Q2 25
$833.8M
$11.3B
Q1 25
$789.2M
$12.6B
Q4 24
$764.9M
$12.9B
Q3 24
$732.5M
$13.6B
Q2 24
$706.5M
$13.9B
Q1 24
$856.2M
$14.0B
Total Assets
MD
MD
XIFR
XIFR
Q4 25
$2.2B
$19.6B
Q3 25
$2.2B
$19.1B
Q2 25
$2.1B
$20.5B
Q1 25
$2.0B
$21.4B
Q4 24
$2.2B
$20.3B
Q3 24
$2.1B
$20.9B
Q2 24
$2.0B
$21.7B
Q1 24
$2.2B
$22.3B
Debt / Equity
MD
MD
XIFR
XIFR
Q4 25
0.66×
0.57×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
0.78×
0.41×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
XIFR
XIFR
Operating Cash FlowLast quarter
$114.1M
$186.0M
Free Cash FlowOCF − Capex
$-88.0M
FCF MarginFCF / Revenue
-35.3%
Capex IntensityCapex / Revenue
110.0%
Cash ConversionOCF / Net Profit
3.39×
6.64×
TTM Free Cash FlowTrailing 4 quarters
$-219.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
XIFR
XIFR
Q4 25
$114.1M
$186.0M
Q3 25
$137.3M
$231.0M
Q2 25
$137.2M
$232.0M
Q1 25
$-117.5M
$90.0M
Q4 24
$133.0M
$283.0M
Q3 24
$91.8M
$208.0M
Q2 24
$107.0M
$231.0M
Q1 24
$-125.2M
$78.0M
Free Cash Flow
MD
MD
XIFR
XIFR
Q4 25
$-88.0M
Q3 25
$-283.0M
Q2 25
$151.0M
Q1 25
$1.0M
Q4 24
$231.0M
Q3 24
$152.0M
Q2 24
$162.0M
Q1 24
$14.0M
FCF Margin
MD
MD
XIFR
XIFR
Q4 25
-35.3%
Q3 25
-89.8%
Q2 25
44.2%
Q1 25
0.4%
Q4 24
78.6%
Q3 24
47.6%
Q2 24
45.0%
Q1 24
5.4%
Capex Intensity
MD
MD
XIFR
XIFR
Q4 25
110.0%
Q3 25
163.2%
Q2 25
23.7%
Q1 25
31.6%
Q4 24
17.7%
Q3 24
17.6%
Q2 24
19.2%
Q1 24
24.9%
Cash Conversion
MD
MD
XIFR
XIFR
Q4 25
3.39×
6.64×
Q3 25
1.91×
Q2 25
3.49×
2.94×
Q1 25
-5.66×
Q4 24
4.36×
Q3 24
4.72×
Q2 24
3.73×
Q1 24
-31.03×
1.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

XIFR
XIFR

Renewable Energy Sales$238.0M96%
Related Party$8.0M3%

Related Comparisons